Cargando…

Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses

The majority of oesophageal adenocarcinoma (OAC) patients do not respond to multimodal treatment regimens and face dismal survival rates. Natural killer (NK) cells are crucial anti-tumour immune cells, and this study investigated the susceptibility of treatment-resistant OAC cells to these potent tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylod, Eimear, McKenna, Ellen, Davern, Maria, Barr, Martin P., Donlon, Noel E., Bibby, Becky A. S., Bhardwaj, Anshul, Reynolds, John V., Lysaght, Joanne, Maher, Stephen G., Conroy, Melissa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224847/
https://www.ncbi.nlm.nih.gov/pubmed/35364779
http://dx.doi.org/10.1007/s10238-022-00811-6
_version_ 1785050285113081856
author Mylod, Eimear
McKenna, Ellen
Davern, Maria
Barr, Martin P.
Donlon, Noel E.
Bibby, Becky A. S.
Bhardwaj, Anshul
Reynolds, John V.
Lysaght, Joanne
Maher, Stephen G.
Conroy, Melissa J.
author_facet Mylod, Eimear
McKenna, Ellen
Davern, Maria
Barr, Martin P.
Donlon, Noel E.
Bibby, Becky A. S.
Bhardwaj, Anshul
Reynolds, John V.
Lysaght, Joanne
Maher, Stephen G.
Conroy, Melissa J.
author_sort Mylod, Eimear
collection PubMed
description The majority of oesophageal adenocarcinoma (OAC) patients do not respond to multimodal treatment regimens and face dismal survival rates. Natural killer (NK) cells are crucial anti-tumour immune cells, and this study investigated the susceptibility of treatment-resistant OAC cells to these potent tumour killers. Natural killer receptor (NKR) ligand expression by OE33CisP (cisplatin-sensitive) and OE33CisR (cisplatin-resistant) cells was investigated. The immunomodulatory effects of OE33CisP and OE33CisR cells on NK cell phenotype and function were assessed. Finally, the impact of chemotherapy regimens on NKR ligand shedding was examined. Our data revealed significantly less surface expression of activating ligands B7-H6, MICA/B, ULBP-3 and activating/inhibitory ligands PVRL-1 and PVRL-4 by OE33CisR cells, compared to OE33CisP cells. Co-culture with OE33CisR cells reduced the frequencies of NKp30(+) and NKp46(+) NK cells and increased frequencies of TIGIT(+), FasL(+) and TRAIL(+) NK cells. Frequencies of IFN-γ-producing NK cells increased while frequencies of TIM-3(+) NK cells decreased after culture with OE33CisP and OE33CisR cells. Frequencies of circulating NKp30(+) NK cells were significantly lower in OAC patients with the poorest treatment response and in patients who received FLOT chemotherapy, while B7-H6 shedding by OAC tumour cells was induced by FLOT. Overall, OE33CisR cells express less activating NKR ligands than OE33CisP cells and have differential effects on NKR expression by NK cells. However, neither cell line significantly dampened NK cell cytokine production, death receptor expression or degranulation. In addition, our data indicate that FLOT chemotherapy may promote B7-H6 shedding and immune evasion with detrimental consequences in OAC patients.
format Online
Article
Text
id pubmed-10224847
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102248472023-05-29 Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses Mylod, Eimear McKenna, Ellen Davern, Maria Barr, Martin P. Donlon, Noel E. Bibby, Becky A. S. Bhardwaj, Anshul Reynolds, John V. Lysaght, Joanne Maher, Stephen G. Conroy, Melissa J. Clin Exp Med Original Article The majority of oesophageal adenocarcinoma (OAC) patients do not respond to multimodal treatment regimens and face dismal survival rates. Natural killer (NK) cells are crucial anti-tumour immune cells, and this study investigated the susceptibility of treatment-resistant OAC cells to these potent tumour killers. Natural killer receptor (NKR) ligand expression by OE33CisP (cisplatin-sensitive) and OE33CisR (cisplatin-resistant) cells was investigated. The immunomodulatory effects of OE33CisP and OE33CisR cells on NK cell phenotype and function were assessed. Finally, the impact of chemotherapy regimens on NKR ligand shedding was examined. Our data revealed significantly less surface expression of activating ligands B7-H6, MICA/B, ULBP-3 and activating/inhibitory ligands PVRL-1 and PVRL-4 by OE33CisR cells, compared to OE33CisP cells. Co-culture with OE33CisR cells reduced the frequencies of NKp30(+) and NKp46(+) NK cells and increased frequencies of TIGIT(+), FasL(+) and TRAIL(+) NK cells. Frequencies of IFN-γ-producing NK cells increased while frequencies of TIM-3(+) NK cells decreased after culture with OE33CisP and OE33CisR cells. Frequencies of circulating NKp30(+) NK cells were significantly lower in OAC patients with the poorest treatment response and in patients who received FLOT chemotherapy, while B7-H6 shedding by OAC tumour cells was induced by FLOT. Overall, OE33CisR cells express less activating NKR ligands than OE33CisP cells and have differential effects on NKR expression by NK cells. However, neither cell line significantly dampened NK cell cytokine production, death receptor expression or degranulation. In addition, our data indicate that FLOT chemotherapy may promote B7-H6 shedding and immune evasion with detrimental consequences in OAC patients. Springer International Publishing 2022-04-01 2023 /pmc/articles/PMC10224847/ /pubmed/35364779 http://dx.doi.org/10.1007/s10238-022-00811-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Mylod, Eimear
McKenna, Ellen
Davern, Maria
Barr, Martin P.
Donlon, Noel E.
Bibby, Becky A. S.
Bhardwaj, Anshul
Reynolds, John V.
Lysaght, Joanne
Maher, Stephen G.
Conroy, Melissa J.
Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title_full Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title_fullStr Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title_full_unstemmed Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title_short Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
title_sort investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224847/
https://www.ncbi.nlm.nih.gov/pubmed/35364779
http://dx.doi.org/10.1007/s10238-022-00811-6
work_keys_str_mv AT mylodeimear investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT mckennaellen investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT davernmaria investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT barrmartinp investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT donlonnoele investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT bibbybeckyas investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT bhardwajanshul investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT reynoldsjohnv investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT lysaghtjoanne investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT maherstepheng investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses
AT conroymelissaj investigatingthesusceptibilityoftreatmentresistantoesophagealtumourstonaturalkillercellmediatedresponses